| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.42B | +0.1% |
| Cost of Revenue | $1.93B | +0.9% |
| R&D Expense | $327.0M | +1.9% |
| SG&A Expense | $1.28B | +1.6% |
| Interest Expense | $277.0M | +14.9% |
| Pre-tax Income | -$1.20B | -1559.7% |
| Income Tax | $36.0M | +500.0% |
| Net Income | -$1.23B | -1478.2% |
| EPS (Basic) | -$2.50 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $352.0M | +2.0% |
| Accounts Receivable | $842.0M | +5.6% |
| Inventory | $1.74B | +12.8% |
| Current Assets | $3.41B | +3.9% |
| Total Assets | $14.36B | -7.3% |
| Current Liabilities | $1.24B | -27.1% |
| Long-term Debt | $5.77B | -1.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $271.0M | -40.0% |
| Capital Expenditures | $140.0M | +2.2% |
| Investing Cash Flow | -$169.0M | +5.6% |
| Financing Cash Flow | -$83.0M | +84.9% |
| Free Cash Flow | $131.0M | -58.4% |
| -1462.5% |
| EPS (Diluted) | -$2.50 | -1462.5% |
| Total Liabilities |
| $8.14B |
| -0.8% |
| Stockholders' Equity | $6.22B | -14.6% |